Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Adalat

02 1AdalatTM

PharmaCompass

01

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 741

2019 Revenue in Millions : 803

Growth (%) : -8

Company Banner

02

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 840

2020 Revenue in Millions : 741

Growth (%) : 24

Company Banner

03

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 873

2021 Revenue in Millions : 840

Growth (%) : 4

Company Banner

04

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 611

2022 Revenue in Millions : 873

Growth (%) : -32

Company Banner

05

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 515

2023 Revenue in Millions : 611

Growth (%) : -16

Company Banner

06

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Antihypertensives

Currency : USD

2015 Revenue in Millions : 647

2014 Revenue in Millions : 696

Growth (%) : 8%

Company Banner

07

Brand Name : AdalatTM

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Antihypertensives

Currency : USD

2014 Revenue in Millions : -2.50%

2013 Revenue in Millions :

Growth (%) :

Company Banner

08

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 804

2016 Revenue in Millions : 774

Growth (%) : 4

Company Banner

09

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 661

2015 Revenue in Millions : 671

Growth (%) : -1

Company Banner

10

Brand Name : Adalat

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Nifedipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 690

2017 Revenue in Millions : 732

Growth (%) : -6%

Company Banner